Results 61 to 70 of about 20,777 (183)
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas +10 more
wiley +1 more source
, 2018 Existe evidencia que sugiere que el bupropión tiene un efecto ...
Mercedes Guaia Memita Guaia
core +1 more source
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
British Journal of Pharmacology, EarlyView.Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
RBD inducido por fármacos- otras clases de antidepresivos
, 2022 Los antidepresivos tricíclicos, la mirtazapina y los inhibidores de la MAO pueden desencadenar el trastorno de conducta del sueño REM (RBD). No se han reportado casos de RBD con trazodona ni bupropión.
Mercedes Guaia Memita Guaia
core +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Prescripción de mirtazapina, bupropión, ATC y MAOI en la población geriátrica
La sedación y la estimulación del apetito producidas por la mirtazapina pueden ser efectos adversos o beneficios terapéuticos según el contexto clínico.
Lauren B. Gerlach
core +1 more source
Frontiers in PsychiatryAlcohol Use Disorder (AUD) is a prevalent condition often co-occurring with affective disorders. Bupropion, a medication used to treat affective disorders, acts by inhibiting dopamine (DA) and norepinephrine (NE) reuptake, potentially helping to ...
Xiangqi Kong +5 more
doaj +1 more source
Bupropion extended-release induced spontaneous orgasms [PDF]
Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2014 Sexual side effects are common with antidepressant use. Spontaneous orgasms have been previously described with several antidepressants. We report the case of a woman who had spontaneous orgasms after starting 300mg/day bupropion extended-release ...
mehmet hamdi orum +2 more
doaj
Acute dystonia after single dose of bupropion
Indian Journal of Psychological Medicine, 2016 Bupropion is an antidepressant that is effective in the treatment of major depressive disorders, smoking cessation, and sexual side effects of selective serotonin reuptake inhibitors.
Forouzan Elyasi, Elham Mahtiyan
doaj +1 more source
British Journal of Pharmacology, EarlyView.Abstract Opioids are prescribed widely for chronic pain despite well‐recognised risks and variable long‐term benefit, reflecting the lack of effective alternatives for many patients. Combination therapies offer a promising strategy to enhance efficacy whilst reducing side effects.
André Mouraux +26 more
wiley +1 more source